# Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

> **NCT01458171** · PHASE3 · COMPLETED · sponsor: **CSL Behring** · enrollment: 23 (actual)

## Conditions studied

- Primary Immune Deficiency Disorder

## Interventions

- **BIOLOGICAL:** Immune globulin subcutaneous (Human)

## Key facts

- **NCT ID:** NCT01458171
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-02
- **Final completion:** 2012-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458171, "Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01458171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*